Randomized clinical trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: Preliminary findings
Eleonardo Pereira Rodrigues, Ana Jardel Batista Fechine, Antonio César Oliveira, Cristiane Francisca Ferreira Matos, Cristiane de Medeiros Passarela, Curt Hemanny, Francimeuda de Morais Dias, José Wilson Batista, Luciana Nogueira Albuquerque, Myrla Sirqueira Soares, Pedro Evangelista Coelho Neto, Vanessa Pires Araújo, Zila Mendes Ayres, Irismar Reis de Oliveira
Abstract
Background/Objective
Obsessive-compulsive disorder (OCD) is the fourth most prevalent and disabling mental disorder. OCD is associated with anatomical and functional changes in the brain, in addition to dysfunctional cognitions. Selective serotonin reuptake inhibitors (SSRIs), cognitive-behavioral therapy (CBT), and exposure and response prevention (ERP) are the treatments of choice. Trial-based cognitive therapy (TBCT) is a recent and empirically validated psychotherapy with a focus on restructuring the dysfunctional negative core beliefs (CBs). The objective of this study was to evaluate the TBCT efficacy relative to ERP in the OCD treatment.
Method
A randomized, single-blind clinical trial was conducted, randomizing 26 patients for individual treatment with TBCT (n = 12) or ERP (n = 14). The groups were evaluated at baseline, at the end of 3 months (12 sessions) and at 3-, 6- and 12-month follow-up.
Results
Both approaches reduced the severity of symptoms with large effect sizes. These results were maintained in the 12-month follow-up assessment.
Conclusion
TBCT may be a valid and promising treatment for this disorder.
Keywords
Submitted date:
02/26/2021
Reviewed date:
04/13/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email